N/A
N=87
Total Hip Arthroplasty (THA) Surgical Techniques Comparing the Direct Anterior Approach to the Posterior Approach
Osteoarthritis of the Hip
Bottom Line
View on ClinicalTrials.gov: NCT01807104 ↗Enrolled (actual)
87
Serious AEs
0.0%
Results posted
Aug 2019
Primary outcome: Primary: Returning to Quality of Life by Using Either Anterior Approach Versus Posterior Approach — 40.1; 43.8 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Anterior Approach / Posterior Approach (Procedure); Anterior versus Posterior Approach for total hip replacement (Procedure)
- Age
- Adult, Older Adult · 20+ yrs
- Sex
- All
- Sponsor
- Barrett, William, M.D.
- Primary completion
- Jul 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Returning to Quality of Life by Using Either Anterior Approach Versus Posterior Approach |
40.1; 43.8 | — |
Summary
The purpose of this study is to compare the short term effectiveness and return to function of subjects undergoing primary Total Hip Arthroplasty using an Anterior Approach (incision on the front part of the hip joint) versus Posterior Approach (incision over back part of the hip joint).
Eligibility Criteria
Inclusion Criteria
- Subject is able to or capable of providing consent to participate in the clinical investigation.
- Subject is between the ages of 20-75 years, inclusive.
- Subject requires a cementless, primary total hip arthroplasty for non-inflammatory degenerative joint disease (NIDJD)
- Subject has sufficient bone stock for the hip replacement device.
- Subject is a suitable candidate for the devices specified in the clinical investigation plan and is willing to be randomized to either surgical approach.
Exclusion Criteria
- Subject in the opinion of the Investigator has an existing condition that would compromise his /her participation and follow-up in this investigation.
- Subject has had previous surgery on the affected hip.
- Subject has significant osteoarthritis of the contra-lateral hip requiring a total hip arthroplasty within 12 months.
Data sourced from ClinicalTrials.gov (NCT01807104). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.